Cell-to-cell miRNA transfer: from body homeostasis to therapy.
about
Fludarabine treatment favors the retention of miR-485-3p by prostate cancer cells: implications for survivalTargeting microRNAs as key modulators of tumor immune responseTargeting MicroRNA Function in Respiratory Diseases: Mini-ReviewThe miR-200 Family: Versatile Players in Epithelial Ovarian CancerMicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancerDiagnostic and therapeutic management of hepatocellular carcinomaQuantitative and stoichiometric analysis of the microRNA content of exosomesCancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.Absolute quantification by droplet digital PCR versus analog real-time PCR.The impact of extracellular vesicle-encapsulated circulating microRNAs in lung cancer researchTumor surveillance by circulating microRNAs: a hypothesis.Circulating miRNAs in cancer: from detection to therapy.Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesisRegulation of cancer metastasis by cell-free miRNAs.Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis.Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathologyInterrelationships of circulating tumor cells with metastasis and thrombosis: role of microRNAsAnalysis of Circulating MicroRNAs In Vivo following Administration of Dexamethasone and Adrenocorticotropin.MicroRNAs and other non-coding RNAs as targets for anticancer drug development.Cross-kingdom inhibition of breast cancer growth by plant miR159.Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis.Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs.MicroRNA signature and function in retinal neovascularization.Role of microRNAs in the trabecular meshwork.MicroRNAs in allergy and asthma.Point-of-care diagnostic tools to detect circulating microRNAS as biomarkers of disease.Genomic alterations as mediators of miRNA dysregulation in ovarian cancer.Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.Liposarcoma: molecular targets and therapeutic implications.Immune regulation in chronic hepatitis C virus infection.A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.microRNA and Allergy.Potential relevance of microRNAs in inter-species epigenetic communication, and implications for disease pathogenesis.Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases.Are Circulating microRNAs Involved in Tumor Surveillance?Cell-to-cell communication: microRNAs as hormones.Differential microRNA profile and post-transcriptional regulation exist in systemic lupus erythematosus patients with distinct autoantibody specificities.Modelling the propagation of a dynamical signature in gene expression mediated by the transport of extracellular microRNAs.
P2860
Q24294497-DDE11150-2EA9-4003-85F3-3AAB3DBE4F0EQ26746972-DE3D1092-AC61-43A0-A8B3-FF671898DBA5Q26766476-E2EC3FFC-9420-4D5F-BFDB-7173A5AE5FB4Q26799353-2E876968-34C7-4B0E-98C6-3ABDD4CE3B9DQ26849525-2BA09573-B4D1-46BF-80F5-929EC728F0B4Q26999043-9B7C111D-C1B8-4C48-A84E-DB406CCCCF38Q30594844-90354057-25D8-4BE8-9812-C1CC8D6BC495Q33591140-4ACBFF84-4A6F-4FE8-ACB6-7A883662888EQ33988019-1289B8BE-8CDE-4CB1-BDCD-A460E7983262Q34252557-0A1418FB-FDF9-42C5-BCC7-B1CFB8253FC9Q34324228-78B300DF-1FDD-4A37-9D2C-B21C0BA93B91Q34728385-B9AC75E5-4F11-4F72-AE21-FB65C0CDF299Q34778143-472888CF-E1AD-4FE8-801F-DA13194A0C82Q35034340-75341072-AEBB-46D0-877F-C2B41E45444EQ35234332-91BEDD97-7F83-4966-97E6-2D53091198A2Q35543094-92D0F0DB-0CBD-4032-A23D-3C77D6689108Q35664886-D742F138-CF70-4D03-B832-98687D9BB480Q35806449-CD89DB14-29A0-480E-A0F6-1882C0F60637Q35994443-7FF27D81-B266-4205-A311-FAB15FCFEB51Q36559965-065F9B09-BCC8-492D-A0E1-0A9FD4D6FD7DQ36790311-9481EFF9-A2B0-40DB-88EA-A7C6EC3EE78BQ37266266-9F4AA010-BAAC-49E8-B777-97C9635AF9F7Q37439272-6EA56E18-5BD8-4A13-86A0-D5CCBCD7CBF1Q37617260-AB17FAA7-ABA7-4AB4-8661-9327728602A9Q37710668-EFF9D2F2-DDD5-400A-B159-9A775279FCFBQ38185939-006621FD-1B42-4B03-87B6-AF7534E321CAQ38214481-0FB96312-3980-4F9E-9F39-DCA083DB8A21Q38256465-182E50DB-1EB9-4B55-BF16-B79C0F28B584Q38366584-22EF3F26-76D2-4E02-9030-BC1C07B08C7FQ38449526-5D05A1E8-2EB8-498E-BDC8-8A8A82D0BFF7Q38833050-5E296E57-CF3B-40ED-B4A3-333A591C9C1EQ38902559-E6104A0D-249A-456B-BBDD-BF1D0EB0E7DAQ38927615-9FCAE103-563C-4B52-B049-A420F9FC191DQ38932407-F1FDB672-9372-4C63-87EE-6960F3FB510CQ38993565-2FDC9A10-4129-4540-965E-122C1E987175Q39096514-7C533508-72E0-4D16-9874-DC059AA4CDFFQ40274014-B8241E25-5ADC-4B2D-94E3-CAA940304EDCQ47113309-2C47217F-26D3-40D4-8C41-F6F6E71E8E7EQ47603082-087EE353-2DC1-418B-921B-5B8C62012489Q47737123-1E590589-BD9A-41C2-B62A-582E25B634A6
P2860
Cell-to-cell miRNA transfer: from body homeostasis to therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cell-to-cell miRNA transfer: from body homeostasis to therapy.
@en
type
label
Cell-to-cell miRNA transfer: from body homeostasis to therapy.
@en
prefLabel
Cell-to-cell miRNA transfer: from body homeostasis to therapy.
@en
P2093
P2860
P1476
Cell-to-cell miRNA transfer: from body homeostasis to therapy.
@en
P2093
M James You
Roxana S Redis
Steliana Calin
Yaling Yang
P2860
P304
P356
10.1016/J.PHARMTHERA.2012.08.003
P577
2012-08-08T00:00:00Z